Applying interventions designed to reduce and manage the symptoms of substance use disorders.
Treatment
SAMHSA Announces $930 Million Funding Opportunity to Combat the Opioid Crisis
The Substance Abuse and Mental Health Services Administration (SAMHSA), an agency within the Department of Health and Human Services (HHS), is now accepting applications for $930 million in State Opioid Response Grants. SAMHSA will...
Using the National Hospital Care Survey (NHCS) to Identify Opioid-Related Hospital Visits
Presenters:
Margaret Noonan, Team Lead, Hospital Care Team, National Center for Health Statistics (NCHS)
Carol DeFrances, Ph.D., Chief, Ambulatory and Hospital Care Statistics Branch, National Center for Health Statistics (NCHS)
Date: Tuesday, June 19, 2018
Application of the Consolidated Framework for Implementation Research to Assess Factors that May Influence Implementation of Tobacco Use Treatment Guidelines in the Viet Nam Public Health Care Delivery System
Abstract Background Services to treat tobacco dependence are not readily available to smokers in low-middle income countries (LMICs) where smoking prevalence remains high. We are conducting a cluster randomized controlled trial comparing...
Ibogaine Treatment Outcomes for Opioid Dependence from a Twelve-Month Follow-Up Observational Study
ABSTRACT Background: The psychoactive indole alkaloid ibogaine has been associated with encouraging treatment outcomes for opioid dependence. The legal status of ibogaine in New Zealand provides a unique opportunity to evaluate durability...
Toxicokinetics of Ibogaine and Noribogaine in a Patient with Prolonged Multiple Cardiac Arrhythmias after Ingestion of Internet Purchased Ibogaine
Abstract Background: Ibogaine is an agent that has been evaluated as an unapproved anti-addictive agent for the management of drug dependence. Sudden cardiac death has been described to occur secondary to its use. We describe the clinical...
Treatment of Opioid Use Disorder with Ibogaine: Detoxification and Drug Use Outcomes
ABSTRACT Background: Ibogaine is a monoterpene indole alkaloid used in medical and nonmedical settings for the treatment of opioid use disorder. Its mechanism of action is apparently novel. There are no published prospective studies of drug...
Seek quality treatment for substance use disorders
This fact sheet can be used as a guide for people seeking mental health treatment. It offers three steps to carry out before using a treatment center, as well as the five signs of a treatment center of quality, which includes reviewing the...
Barriers to Addiction Prevention and Treatment in Communities with Organized Crime: The Perspective of Health Providers
ABSTRACT Introduction: The presence of organized crime may encourage an increase in the supply of illicit substances, the incorporation of young people into crime, the promotion of substance-oriented lifestyles, and the use of violent...
Dilemmas in Recovery‑Oriented Practice to Support People with Co‑Occurring Mental Health and Substance Use Disorders
Abstract Background Recovery-oriented practice is recommended in services for people with co-occurring mental health and substance use disorders. Understanding practitioners’ perceptions of recovery-oriented services may be a key component...
European Drug Report 2018
The European Monitoring Centre on Drugs and Drug Addiction (EMCDDA) has released their latest European Drugs report. Covering 30 European countries the report explores drug trends, developments in prevention and treatment, public health...
